Rare Disease Day 2022: Huntington's Disease
Huntington’s Disease is a genetically inherited disorder which affects the nervous system, causing progressive changes in movement, learning, thinking and ...Read more >
News
Rare Disease Day 2022: Niemann-Pick Disease
Niemann-Pick Disease is a genetic disorder caused by autosomal recessive mutations in genes relating to lipid metabolism. The condition presents ...Read more >
Women in Science: Interview
Karen McCusker, Associate Director in Marketing at Simbec-Orion, speaks to Dr Debra Davies and Romillie Cruz at Simbec-Orion on their ...Read more >
Lupuzor™ Phase III Trials: Partnering With Immupharma
Lupuzor™ is an in-development treatment for Lupus, a chronic inflammatory disease thought to affect around 5 million people worldwide. Having ...Read more >
Using biomarker clinical trial design to drive rare respiratory disease results
Simbec-Orion recently helped a biotech sponsor demonstrate the safety and tolerability of a new trial treatment for idiopathic pulmonary fibrosis ...Read more >
What Are the Three Stages Of Clinical Trials?
Clinical trials involve a series of studies that test the safety and effectiveness of drugs and other medical treatments. To ...Read more >
Types Of Signal In Pharmacovigilance
Pharmacovigilance is concerned with detecting the possible risks associated with a drug or treatment. Risks are monitored and assessed throughout ...Read more >
What’s the difference between Phase 2 and Phase 3 Clinical Trials?
In previous years, pharmacology and clinical trials were topics which mainly interested medical professionals, rather than the public. However, as ...Read more >
What is Clinical Pharmacology and Therapeutics?
Clinical pharmacology and therapeutics is the science of medicines and how they are used to diagnose, prevent and treat diseases ...Read more >
Rare Diseases: Everything you need to know
In the UK alone, it’s estimated that around 3 million people are living with a rare disease or condition. The ...Read more >
Pulmonary Deposition of BUD/Glycopyrrolate/Formoterol in COPD Patients
A scintigraphy study of budesonide/ glycopyrrolate/ formoterol fumarate metered dose inhaler in patients with moderate‑to‑very severe chronic obstructive pulmonary disease. ...Read more >
Fundraising for Findacure for Rare Disease Day 2021
As a CRO specialising in clinical trials for rare and orphan diseases, Rare Disease Day has become a special cause ...Read more >